SLT 0.00% 0.7¢ select exploration limited

gmt what are your thoughts on report?, page-5

  1. 298 Posts.
    re: thoughts on shaw report I have just seen the report and think it's very conservative.

    Keep in mind:
    1. They estimate 5% royalty, when I would expect 10%
    2. Their 2005 estimates only include 2m Hep C kits (ie 1st year in ramp up mode). But full operational mode may indicate many times that. With 170m chronic sufferers and 3-4m new cases per year, I would expect that figure to be at least 10m kits per year rather than 2m.

    If you take the above into account, the revenue would move from US$6.5m (as per Shaw report) to US$48.6m, again, assuming:
    - 10% royalty
    - full operation with Hep C

    Given very low overheads on this revenue, this is huge!

    Have I missed the plot with these numbers?
 
watchlist Created with Sketch. Add SLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.